Latest news with #Valuation
Yahoo
3 days ago
- Business
- Yahoo
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Intrinsic Value Is Potentially 17% Below Its Share Price
Using the 2 Stage Free Cash Flow to Equity, LeMaitre Vascular fair value estimate is US$67.98 LeMaitre Vascular's US$82.20 share price signals that it might be 21% overvalued Analyst price target for LMAT is US$105, which is 54% above our fair value estimate In this article we are going to estimate the intrinsic value of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex. We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF ($, Millions) US$50.0m US$58.8m US$71.3m US$67.4m US$74.8m US$78.9m US$82.6m US$86.0m US$89.3m US$92.4m Growth Rate Estimate Source Analyst x4 Analyst x4 Analyst x2 Analyst x1 Analyst x1 Est @ 5.43% Est @ 4.69% Est @ 4.16% Est @ 3.80% Est @ 3.54% Present Value ($, Millions) Discounted @ 7.4% US$46.5 US$50.9 US$57.5 US$50.6 US$52.3 US$51.3 US$50.0 US$48.5 US$46.8 US$45.2 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$500m The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.9%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.4%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = US$92m× (1 + 2.9%) ÷ (7.4%– 2.9%) = US$2.1b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$2.1b÷ ( 1 + 7.4%)10= US$1.0b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$1.5b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of US$82.2, the company appears slightly overvalued at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent. The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at LeMaitre Vascular as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.4%, which is based on a levered beta of 1.036. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. View our latest analysis for LeMaitre Vascular Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Dividends are covered by earnings and cash flows. Weakness Dividend is low compared to the top 25% of dividend payers in the Medical Equipment market. Expensive based on P/E ratio and estimated fair value. Opportunity Annual earnings are forecast to grow for the next 3 years. Threat Annual earnings are forecast to grow slower than the American market. Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. Why is the intrinsic value lower than the current share price? For LeMaitre Vascular, we've compiled three essential aspects you should further research: Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with LeMaitre Vascular , and understanding it should be part of your investment process. Future Earnings: How does LMAT's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every American stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Effettua l'accesso per consultare il tuo portafoglio
Yahoo
13-05-2025
- Business
- Yahoo
Pando Ridge Ventures Launches a Business Valuation Service
SALT LAKE CITY, May 13, 2025--(BUSINESS WIRE)--Pando Ridge Ventures has partnered with BizEquity to launch a new Business Valuation Service, giving company leaders across the country access to real-time valuation insights at no cost. The service is now live and available to founders, CEOs and business owners seeking clarity on their company's value. The initiative is part of Pando Ridge Ventures' ongoing mission to provide founders and business leaders with the tools they need to grow, transition and fund their companies more strategically. By leveraging BizEquity's industry-leading valuation technology, the firm's specialists can now quickly offer detailed, data-driven valuation reports. "This service meets three of the most pressing needs we see in today's market," said Erik Blomquist, Managing Partner at Pando Ridge Ventures. "Startup leaders exploring early-stage funding need to understand their pre-money and post-money valuation to make intelligent capital decisions. Growing companies seeking to raise capital for their next stage of growth need accurate, up-to-date insights to attract and align with the right money sources." The Business Valuation Service is accessible through the Pando Ridge Ventures website and is intended to support long-term relationships between specialists and the business owners they serve. "The market is seeing a major evolution in that we're seeing a wave of business owners nearing retirement, who are part of the so-called 'silver tsunami,'" said Mike Lewis, General Partner at Pando Ridge Ventures. "These people have built companies over several decades and now need help navigating succession planning, tax strategies and exit opportunities for them and their families. Our new valuation tool brings clarity and confidence to all of them." For more information and to access the valuation tool, visit About Pando Ridge Ventures Pando Ridge Ventures is a private investment firm that partners with visionary founders and forward-thinking businesses to accelerate growth and long-term value creation. With a focus on innovation, operational excellence and strategic guidance, Pando Ridge supports companies at every stage—from early growth to expansion and succession. The firm brings a collaborative approach, deep industry insight and access to a trusted network of advisors and capital partners. Pando Ridge is headquartered in Salt Lake City and invests across a diverse range of sectors, including technology, building and construction materials, manufacturing and lifestyle industries. Learn more at View source version on Contacts Media Contact: Tim RushPando Ridge Venturestim@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Mint
30-04-2025
- Business
- Mint
What the Grant Thornton audit found at IndusInd Bank
Mumbai: Erstwhile deputy chief executive of IndusInd Bank Arun Khurana was well aware of the incorrect accounting of derivative trades that led to a ₹ 1,959 crore hole in its books, a forensic audit by accounting and consulting firm Grant Thornton found. According to two people aware of the audit, during the probe, auditors found out that Khurana was aware of the fact that these trades were wrong. 'The team went through email trails and saw that Khurana knew. There was an instance of him not paying heed to red flags raised by the finance department which found out about it," one of the two people said on the condition of anonymity. The bank did not respond to an email seeking comments on the story. A call and a text message to Khurana remained unanswered as well. An email sent to Grant Thornton did not elicit a response. Khurana, who had joined IndusInd Bank in November 2011 from the Royal Bank of Scotland, Singapore, resigned on 28 April, two days after Grant Thornton submitted its report. The bank said on 20 March that it has appointed an independent professional firm to identify the root cause of the discrepancies, assess the correctness and impact of the accounting treatment of the derivative contracts, and establish accountability. Reuters reported three days later that IndusInd Bank had appointed Grant Thornton to conduct a forensic review into accounting lapses. This report was submitted to the bank on 26 April. In an exchange filing on 27 April, the bank said that the report has pegged the cumulative adverse accounting impact at ₹ 1959.98 crore as on 31 March. It also said that the problem lay in 'incorrect accounting of internal derivative trades" and that the report examined the roles and actions of key employees in this context. 'When the audit team questioned some bankers at IndusInd Bank, their stories did not match. The team was trying to look for a rationale behind not accounting for the trades correctly and they were unable to answer," said the person. The findings of the audit team are in contrast to what Khurana told analysts on 10 March when the bank first disclosed these discrepancies. Answering a question about when these derivative transactions took place, Khurana said, 'It's about a process that was put in place, which we realized now, based on this new framework that we had to adopt on 1 April". The framework referred to here refers to the norms issued in September 2023 under the RBI Master Direction - Classification, Valuation and Operation of Investment Portfolio of Commercial Banks (Directions). This came into force on 1 April, 2024. 'The Grant Thornton audit stops at finding out the hit on the bank and fixing accountability on people, while the rest is for the board to do," the person said. To be sure, the bank said on 27 April that the board is taking necessary steps to fix accountability for the persons responsible for these lapses and re-align the roles and responsibilities of senior management. After Khurana's exit on 28 April, chief executive Sumant Kathpalia resigned on Tuesday, stating he takes 'moral responsibility." Since 2013, IndusInd Bank has used a solution from global capital markets platform provider Calypso Technology for its derivatives trades. The bank had said in 2013 that it is looking to 'fuel its ambitious growth plan by offering its customers sophisticated treasury products and providing them wider access to the markets." According to the person cited earlier, however, the internal hedges were not recorded by the lender, leading to a mismatch that blew up later. The Reserve Bank of India (RBI) on Wednesday allowed the IndusInd Bank board to constitute a committee of executives to run the bank after Kathpalia's exit. Suresh Ganapathy, managing director and head of financial services research at Macquarie Capital was surprised at the turn of events. 'The chairman is Sunil Mehta who, in fact, was appointed by the government on Yes Bank board when it became insolvent, in order to save and revive the bank. With such an illustrious pedigree of so many board members, it is surprising what has happened," Ganapathy wrote to clients. Others pointed to investor concerns. 'We have observed growing investor concerns regarding near-term profitability and the strength of the balance sheet (assets and liabilities) amid these developments," analysts at Kotak Institutional Equities wrote in a note to clients on Wednesday. 'However, it is important to note that similar situations have occurred in the recent past and many of these concerns have not materialized, except for a few instances (Yes Bank episode)."
